HEADER COMPLEX (TOXIN/PEPTIDE) 22-OCT-96 1EXF TITLE EXFOLIATIVE TOXIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXFOLIATVE TOXIN A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ETA; COMPND 5 EC: 3.4.21.- SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 1280; SOURCE 4 STRAIN: MNEV KEYWDS COMPLEX (TOXIN-PEPTIDE), HYDROLASE, SERINE PROTEASE, SUPERANTIGEN, KEYWDS 2 COMPLEX (TOXIN-PEPTIDE) COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.M.VATH,C.A.EARHART,J.V.RAGO,M.H.KIM,G.A.BOHACH,P.M.SCHLIEVERT, AUTHOR 2 D.H.OHLENDORF REVDAT 4 13-MAR-24 1EXF 1 SOURCE REVDAT 3 07-FEB-24 1EXF 1 REMARK REVDAT 2 24-FEB-09 1EXF 1 VERSN REVDAT 1 25-FEB-98 1EXF 0 JRNL AUTH G.M.VATH,C.A.EARHART,J.V.RAGO,M.H.KIM,G.A.BOHACH, JRNL AUTH 2 P.M.SCHLIEVERT,D.H.OHLENDORF JRNL TITL THE STRUCTURE OF THE SUPERANTIGEN EXFOLIATIVE TOXIN A JRNL TITL 2 SUGGESTS A NOVEL REGULATION AS A SERINE PROTEASE. JRNL REF BIOCHEMISTRY V. 36 1559 1997 JRNL REFN ISSN 0006-2960 JRNL PMID 9048539 JRNL DOI 10.1021/BI962614F REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.7 REMARK 3 NUMBER OF REFLECTIONS : 16869 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.204 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1896 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 107 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.498 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : 1.090 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 GLY 300: GLYCINE WAS MODELED INTO TO A STRONG FO-FC FEATURE DUE TO REMARK 3 THE SHAPE AND ENVIRONMENT OF THE FEATURE REMARK 3 REMARK 3 THE SIDE CHAINS OF RESIDUES GLU 1E, GLU1F, AND ARG 221A REMARK 3 WERE NOT VISIBLE BEYOND CB. THEREFORE THE OCCUPANCY OF REMARK 3 THESE ATOMS WERE SET TO 0. THE CONFORMATION OF THESE REMARK 3 SIDE CHAINS WERE TAKEN FROM ANOTHER CRYSTAL FORM OF ETA REMARK 3 (MONOCLINIC FORM). REMARK 3 REMARK 3 GLY 300: GLYCINE WAS MODELED INTO TO A STRONG FO-FC REMARK 3 FEATURE DUE TO THE SHAPE AND ENVIRONMENT OF THE FEATURE. REMARK 4 REMARK 4 1EXF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000173184. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-95 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : SIEMENS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XENGEN REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16869 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 17.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.7 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07230 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: REFINEMENT INCLUDED BULK SOLVENT CORRECTION. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.43000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 35.75000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 35.75000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 92.14500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 35.75000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 35.75000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 30.71500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 35.75000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 35.75000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 92.14500 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 35.75000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 35.75000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.71500 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 61.43000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ETA IS STRUCTURALLY HOMOLOGOUS TO THE CHYMOTRYPSIN-LIKE REMARK 400 SERINE PROTEASES. PEPTIDE BOND CLEAVAGE, HOWEVER, HAS NOT REMARK 400 BEEN DEMONSTRATED. REMARK 400 REMARK 400 ETA IS MITOGENIC FOR T LYMPHOCYTES AND REPORTED TO BE A REMARK 400 SUPERANTIGEN. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 1A REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 1E CG CD OE1 OE2 REMARK 480 GLU A 1F CG CD OE1 OE2 REMARK 480 LYS A 16 CG CD CE NZ REMARK 480 ARG A 221A CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH TYR A 26D H LYS A 122 1.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 221A NE - CZ - NH2 ANGL. DEV. = 3.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 39 -62.42 -123.36 REMARK 500 ALA A 42 -156.20 -126.27 REMARK 500 GLU A 91 59.27 -152.21 REMARK 500 THR A 164 63.63 33.53 REMARK 500 SER A 215 -163.45 -167.84 REMARK 500 LEU A 220 -56.71 71.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: CATALYTIC SITE. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLY A 300 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ETA NUMBERING BASED ON STRUCTURAL SIMILARITY TO REMARK 999 CHYMOTRYPSIN (W.BODE ET AL., 1989, EMBO J. 8,3467-3475). DBREF 1EXF A 1A 243 UNP P09331 ETA_STAAU 39 280 SEQRES 1 A 242 GLU VAL SER ALA GLU GLU ILE LYS LYS HIS GLU GLU LYS SEQRES 2 A 242 TRP ASN LYS TYR TYR GLY VAL ASN ALA PHE ASN LEU PRO SEQRES 3 A 242 LYS GLU LEU PHE SER LYS VAL ASP GLU LYS ASP ARG GLN SEQRES 4 A 242 LYS TYR PRO TYR ASN THR ILE GLY ASN VAL PHE VAL LYS SEQRES 5 A 242 GLY GLN THR SER ALA THR GLY VAL LEU ILE GLY LYS ASN SEQRES 6 A 242 THR VAL LEU THR ASN ARG HIS ILE ALA LYS PHE ALA ASN SEQRES 7 A 242 GLY ASP PRO SER LYS VAL SER PHE ARG PRO SER ILE ASN SEQRES 8 A 242 THR ASP ASP ASN GLY ASN THR GLU THR PRO TYR GLY GLU SEQRES 9 A 242 TYR GLU VAL LYS GLU ILE LEU GLN GLU PRO PHE GLY ALA SEQRES 10 A 242 GLY VAL ASP LEU ALA LEU ILE ARG LEU LYS PRO ASP GLN SEQRES 11 A 242 ASN GLY VAL SER LEU GLY ASP LYS ILE SER PRO ALA LYS SEQRES 12 A 242 ILE GLY THR SER ASN ASP LEU LYS ASP GLY ASP LYS LEU SEQRES 13 A 242 GLU LEU ILE GLY TYR PRO PHE ASP HIS LYS VAL ASN GLN SEQRES 14 A 242 MET HIS ARG SER GLU ILE GLU LEU THR THR LEU SER ARG SEQRES 15 A 242 GLY LEU ARG TYR TYR GLY PHE THR VAL PRO GLY ASN SER SEQRES 16 A 242 GLY SER GLY ILE PHE ASN SER ASN GLY GLU LEU VAL GLY SEQRES 17 A 242 ILE HIS SER SER LYS VAL SER HIS LEU ASP ARG GLU HIS SEQRES 18 A 242 GLN ILE ASN TYR GLY VAL GLY ILE GLY ASN TYR VAL LYS SEQRES 19 A 242 ARG ILE ILE ASN GLU LYS ASN GLU HET GLY A 300 8 HETNAM GLY GLYCINE FORMUL 2 GLY C2 H5 N O2 FORMUL 3 HOH *107(H2 O) HELIX 1 1 ALA A 1D TYR A 7 1 15 HELIX 2 2 ALA A 11 ASN A 13 5 3 HELIX 3 3 GLU A 24 GLN A 26B 1 5 HELIX 4 4 TYR A 27 THR A 29 5 3 HELIX 5 5 ARG A 56 ALA A 62 1 7 HELIX 6 6 PRO A 62D LYS A 63 5 3 HELIX 7 7 LEU A 112 ASP A 114 5 3 HELIX 8 8 SER A 126 ASP A 129 5 3 HELIX 9 9 LEU A 165 ARG A 179 5 3 HELIX 10 10 PRO A 192 ASN A 194 5 3 HELIX 11 11 ASN A 232A LYS A 241 1 10 SHEET 1 A 8 PHE A 19 LYS A 21 0 SHEET 2 A 8 MET A 155 GLU A 161 -1 N ARG A 157 O SER A 20 SHEET 3 A 8 LYS A 135 TYR A 141 -1 N GLY A 140 O HIS A 156 SHEET 4 A 8 GLY A 198 PHE A 200 -1 N PHE A 200 O GLU A 137 SHEET 5 A 8 LEU A 209 SER A 218 -1 N GLY A 211 O ILE A 199 SHEET 6 A 8 GLN A 224 GLY A 230 -1 N VAL A 229 O ILE A 212 SHEET 7 A 8 LEU A 181 TYR A 184 -1 N TYR A 183 O ASN A 226 SHEET 8 A 8 GLU A 161 THR A 163 -1 N THR A 163 O ARG A 182 SHEET 1 B 3 THR A 40 VAL A 45 0 SHEET 2 B 3 ILE A 30 VAL A 35 -1 N VAL A 35 O THR A 40 SHEET 3 B 3 VAL A 64 PRO A 68 -1 N ARG A 67 O ASN A 32 SHEET 1 C 3 THR A 51 THR A 54 0 SHEET 2 C 3 ALA A 104 LEU A 108 -1 N ILE A 106 O VAL A 52 SHEET 3 C 3 VAL A 85 LEU A 89 -1 N LEU A 89 O LEU A 105 SHEET 1 D 2 ILE A 70 THR A 72 0 SHEET 2 D 2 THR A 77 THR A 79 -1 N GLU A 78 O ASN A 71 CISPEP 1 TYR A 26D PRO A 26E 0 0.17 SITE 1 CAT 3 ASP A 102 HIS A 57 SER A 195 SITE 1 AC1 5 LYS A 21 GLU A 24 ARG A 26A ASN A 71 SITE 2 AC1 5 HOH A 407 CRYST1 71.500 71.500 122.860 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013986 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013986 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008139 0.00000